2American college of chest physicians/society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992,20 (6):864-874.
3Gutierrez G,Palizas F,Doglio G,et al.Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients.Lancet,1992,339(8787):195-199.
4Marik PE,Mohedin M.The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.JAMA,1994,272(17):1354-1357.
5Sands KE,Bates DW,Lanken PN,et al.Epidemiology of sepsis syndrome in 8 academic medical centers.Academic medical center consortium sepsis project working group.JAMA,1997,278(3):234-240.
6Ruokonen E,Parviainen I,Uusaro A.Treatment of impaired perfusion in septic shock.Ann Med,2002,34(7-8):590-597.
8Boffa JJ,Arendshorst WJ.Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.J Am Soc Nephrol,2005,16:117-124.
9Holmes CL.Vasoactive drugs in the intensive care unit.Curr Opin Crit Care,2005,11:413-417.
10Bellomo R,Giantomasso DD.Noradrenaline and the kidney:friends or foes? Crit Care,2001,5:294-298.
